Skip to main content
SpringerLink
Log in

Etiology and Epidemiology of MDS

  • Chapter
Hematologic Malignancies: Myelodysplastic Syndromes

Part of the book series: Hematologic Malignancies ((HEMATOLOGIC))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 139.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  • Aksoy M, Erdem S (1978) Followup study on the mortality and the development of leukemia in 44 pancytopenic patients with chronic exposure to benzene. Blood 52:285–292

    PubMed  CAS  Google Scholar 

  • Aksoy M, Dincol K, Erdem S, Dincol G (1972) Acute leukemia due to chronic exposure to benzene. Am J Med 52:160–166

    Article  PubMed  CAS  Google Scholar 

  • Armitage JO, Carbone PP, Connors JM, Levine A, Bennett JM, Kroll S (2003) Treatment-related myelodysplasia and acute leukemia in non-Hodgkin’s lymphoma patients (Review). J Clin Oncol 21:897–906

    Article  PubMed  Google Scholar 

  • Aul C, Germing U, Gattermann N, Minning H (1998) Increasing incidence of myelodysplastic syndromes: real or fictitious? Leuk Res 22:93–100

    Article  PubMed  CAS  Google Scholar 

  • Bjork J, Albin M, Mauritzson N, Stromberg U, Johansson B, Hagmar L (2000) Smoking and myelodysplastic syndromes. Epidemiology 11:285–291

    Article  PubMed  CAS  Google Scholar 

  • Brown WM, Doll R (1965) Mortality from cancer and other causes after radiotherapy for ankylosing spondylitis. Br Med J 5474:1327–1332

    PubMed  CAS  Google Scholar 

  • Brownson RC, Novotny TE, Perry MC (1993) Cigarette smoking and adult leukemia. A meta-analysis. Arch Intern Med 153:469–475

    Article  PubMed  CAS  Google Scholar 

  • Deeg HJ, Jiang PYZ, Holmberg LA, Scott B, Petersdorf EW, Appelbaum FR (2004) Hematologic responses of patients with MDS to antithymocyte globulin plus etanercept correlate with improved flow scores of marrow cells. Leuk Res 28:1177–1180

    Article  PubMed  Google Scholar 

  • Gattermann N (2004) Mitochondrial DNA mutations in the hematopoietic system. Leukemia 18:18–22

    Article  PubMed  CAS  Google Scholar 

  • Gattermann N, Wulfert M, Junge B, Germing U, Haas R, Hofhaus G (2004) Ineffective hematopoiesis linked with a mitochondrial tRNA mutation (G3242A) in a patient with myelodysplastic syndrome. Blood 103:1499–1502

    PubMed  CAS  Google Scholar 

  • Germing U, Strupp C, Kundgen A, Bowen D, Aul C, Haas R, Gattermann N (2004) No increase in age-specific incidence of myelodysplastic syndromes. Haematologica 89:905–910

    PubMed  Google Scholar 

  • Goldberg H, Lusk E, Moore J, Nowell PC, Besa EC (1990) Survey of exposure to genotoxic agents in primary myelodysplastic syndrome: correlation with chromosome patterns and data on patients without hematological disease. Cancer Res 50:6876–6881

    PubMed  CAS  Google Scholar 

  • Gowans D, O’Sullivan A, Rollinson S, Roddam P, Groves M, Fegan C, Morgan G, Bowen D (2002) Allele and haplotype frequency at human leucocyte antigen class l/ll and immunomodulatory cytokine loci in patients with myelodysplasia and acute myeloid leukaemia: in search of an autoimmune aetiology. Br J Haematol 117:541–545

    Article  PubMed  CAS  Google Scholar 

  • Ido M, Nagata C, Kawakami N, Shimizu H, Yoshida Y, Nomura T, Mizoguchi H (1996) A case-control study of myelodysplastic syndromes among Japanese men and women. Leuk Res 20:727–731

    Article  PubMed  CAS  Google Scholar 

  • Kirkwood TB, Austad SN (2000) Why do we age? (Review). Nature 408:233–238

    Article  PubMed  CAS  Google Scholar 

  • Kojima S, Ohara A, Tsuchida M, Kudoh T, Hanada R, Okimoto Y, Kaneko T, Takano T, Ikuta K, Tsukimoto I (2002) Risk factors for evolution of acquired aplastic anemia into myelodysplastic syndrome and acute myeloid leukemia after immunosuppressive therapy in children. Blood 100:786–790

    PubMed  CAS  Google Scholar 

  • Kutler Dl, Singh B, Satagopan J, Batish SD, Berwick M, Giampietro PF, Hanenberg H, Auerbach AD (2003) A 20-year perspective on the International Fanconi Anemia Registry (IFAR). Blood 101:1249–1256

    Article  PubMed  CAS  Google Scholar 

  • Lucas GS, West RR, Jacobs A (1989) Familial myelodysplasia. BMJ 299:551

    PubMed  CAS  Google Scholar 

  • Luna-Fineman S, Shannon KM, Lange BJ (1995) Childhood monosomy 7: epidemiology, biology, and mechanistic implications (Review). Blood 85:1985–1999

    PubMed  CAS  Google Scholar 

  • Maciejewski JP, Risitano A, Sloand EM, Nunez O, Young NS (2002) Distinct clinical outcomes for cytogenetic abnormalities evolving from aplastic anemia. Blood 99:3129–3135

    Article  PubMed  CAS  Google Scholar 

  • Marley SB, Lewis JL, Davidson RJ, Roberts IA, Dokal I, Goldman JM, Gordon MY (1999) Evidence for a continuous decline in haemopoietic cell function from birth: application to evaluating bone marrow failure in children. Br J Haematol 106:162–166

    Article  PubMed  CAS  Google Scholar 

  • Matsuo T, Tomonaga M, Bennett JM, Kuriyama K, Imanaka F, Kuramoto A, Kamada N, Ichimaru M, Finch SC, Pisciotta AV (1988) Reclassification of leukemia among A-bomb survivors in Nagasaki using French-American-British (FAB) classification for acute leukemia. Jpn J Clin Oncol 18:91–96

    PubMed  CAS  Google Scholar 

  • Mauritzson N, Albin M, Rylander L, Billstrom R, Ahlgren T, Mikoczy Z, Bjork J, Stromberg U, Nilsson PG, Mitelman F, Hagmar L, Johansson B (2002) Pooled analysis of clinical and cytogenetic features in treatment-related and de novo adult acute myeloid leukemia and myelodysplastic syndromes based on a consecutive series of 761 patients analyzed 1976–1993 and on 5098 unselected cases reported in the literature 1974–2001. Leukemia 16:2366–2378

    Article  PubMed  CAS  Google Scholar 

  • Mele A, Szklo M, Visani G, Stazi MA, Castelli G, Pasquini P, Mandelli F (1994) Hair dye use and other risk factors for leukemia and preleukemia: a case-control study. Italian Leukemia Study Group. Am J Epidemiol 139:609–619

    PubMed  CAS  Google Scholar 

  • Metayer C, Curtis RE, Vose J, Sobocinski KA, Horowitz MM, Bhatia S, Fay JW, Freytes CO, Goldstein SC, Herzig RH, Keating A, Miller CB, Nevill TJ, Pecora AL, Rizzo JD, Williams SF, Li CY, Travis LB, Weisdorf DJ (2003) Myelodysplastic syndrome and acute myeloid leukemia after autotransplantation for lymphoma: a multicenter case-control study. Blood 101:2015–2023

    Article  PubMed  CAS  Google Scholar 

  • Moloney WC (1987) Radiogenic leukemia revisited. Blood 70:905–908

    PubMed  CAS  Google Scholar 

  • Nagata C, Shimizu H, Hirashima K, Kakishita E, Fujimura K, Niho Y, Karasawa M, Oguma S, Yoshida Y, Mizoguchi H (1999) Hair dye use and occupational exposure to organic solvents as risk factors for myelodysplastic syndrome. Leuk Res 23:57–62

    Article  PubMed  CAS  Google Scholar 

  • Nilsson-Ehle H, Jagenburg R, Landahl S, Svanborg A (2000) Blood haemoglobin declines in the elderly: implications for reference intervals from age 70 to 88. Eur J Haematol 65:297–305

    Article  PubMed  CAS  Google Scholar 

  • Nisse C, Lorthois C, Dorp V, Eloy E, Haguenoer JM, Fenaux P (1995) Exposure to occupational and environmental factors in myelodysplastic syndromes. Preliminary results of a case-control study. Leukemia 9:693–699

    PubMed  CAS  Google Scholar 

  • Nisse C, Haguenoer JM, Grandbastien B, Preudhomme C, Fontaine B, Brillet JM, Lejeune R, Fenaux P (2001) Occupational and environmental risk factors of the myelodysplastic syndromes in the North of France. Br J Haematol 112:927–935

    Article  PubMed  CAS  Google Scholar 

  • Pasqualetti P, Festuccia V, Acitelli P, Collacciani A, Giusti A, Casale R (1997) Tobacco smoking and risk of haematological malignancies in adults: a case-control study. Br J Haematol 97:659–662

    Article  PubMed  CAS  Google Scholar 

  • Pedersen-Bjergaard J, Pedersen M, Myhre J, Geisler C (1997) High risk of therapy-related leukemia after BEAM chemotherapy and autologous stem cell transplantation for previously treated lymphomas is mainly related to primary chemotherapy and not to the BEAM-transplantation procedure. Leukemia 11:16541–660

    Google Scholar 

  • Pedersen-Bjergaard J, Andersen MK, Christiansen DH, Nerlov C (2002a) Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia. Blood 99:1909–1912

    Article  PubMed  CAS  Google Scholar 

  • Pedersen-Bjergaard J, Christiansen DH, Andersen MK, Skovby F (2002b) Causality of myelodysplasia and acute myeloid leukemia and their genetic abnormalities (Review). Leukemia 16:2177–2184

    Article  PubMed  CAS  Google Scholar 

  • Qian Z, Fernald AA, Godley LA, Larson RA, Le Beau MM (2002) Expression profiling of CD34+ hematopoietic stem/progenitor cells reveals distinct subtypes of therapy-related acute myeloid leukemia. Proc Natl Acad Sci USA 99:14925–14930

    PubMed  CAS  Google Scholar 

  • Reizenstein P, Dabrowski L (1991) Increasing prevalence of the myelodysplastic syndrome: an international Delphi study. Anticancer Res 11:1069–1070

    PubMed  CAS  Google Scholar 

  • Rigolin GM, Cuneo A, Roberti MG, Bardi A, Bigoni R, Piva N, Minotto C, Agostini P, De Angeli C, Del Senno L, Spanedda R, Castoldi G (1998) Exposure to myelotoxic agents and myelodysplasia: case-control study and correlation with clinicobiological findings. Br J Haematol 103:189–197

    Article  PubMed  CAS  Google Scholar 

  • Rothman N, Smith MT, Hayes RB, Traver RD, Hoener B, Campleman S, Li GL, Dosemeci M, Linet M, Zhang L, Xi L, Wacholder S, Lu W, Meyer KB, Titenko-Holland N, Stewart JT, Yin S, Ross D (1997) Benzene poisoning, a risk factor for hematological malignancy, is associated with the NQO1 609C→T mutation and rapid fractional excretion of chlorzoxazone. Cancer Res 57:2839–2842

    PubMed  CAS  Google Scholar 

  • Saunthararajah Y, Nakamura R, Nam JM, Robyn J, Loberiza F, Maciejewski JP, Simonis T, Molldrem J, Young NS, Barrett AJ (2002) HLA-DR15 (DR2) is overrepresented in myelodysplastic syndrome and aplastic anemia and predicts a response to immunosuppression in myelodysplastic syndrome. Blood 100:1570–1574

    PubMed  CAS  Google Scholar 

  • Shin MG, Kajigaya S, Levin BC, Young NS (2003) Mitochondrial DNA mutations in patients with myelodysplastic syndromes. Blood 101:3118–3125

    Article  PubMed  CAS  Google Scholar 

  • Smith MT, Zhang L, Jeng M, Wang Y, Guo W, Duramad P, Hubbard AE, Hofstadler G, Holland NT (2000) Hydroquinone, a benzene metabolite, increases the level of aneusomy of chromosomes 7 and 8 in human CD34-positive blood progenitor cells. Carcinogenesis 21:1485–1490

    Article  PubMed  CAS  Google Scholar 

  • Socié G (1996) Could aplastic anaemia be considered a pre-pre-leukaemic disorder? (Review). Eur J Haematol Supplementum 60:60–63

    Google Scholar 

  • Travis LB, Li CY, Zhang ZN, Li DG, Yin SN, Chow WH, Li GL, Dosemeci M, Blot W, Fraumeni JFJ (1994) Hematopoietic malignancies and related disorders among benzene-exposed workers in China (Review). Leukemia & Lymphoma 14:91–102

    CAS  Google Scholar 

  • Van Zant G (2003) Genetic control of stem cells: implications for aging (Review). Int J Hematol 77:29–36

    Article  PubMed  Google Scholar 

  • Van Zant G, Liang Y (2003) The role of stem cells in aging (Review). Exp Hematol 31:659–672

    PubMed  Google Scholar 

  • Voytek PE, Thorslund TW (1991) Benzene risk assessment: status of quantifying the leukemogenic risk associated with the low-dose inhalation of benzene (Review). Risk Anal 11:355–357

    PubMed  CAS  Google Scholar 

  • West RR, Stafford DA, Farrow A, Jacobs A (1995) Occupational and environmental exposures and myelodysplasia: a case-control study. Leuk Res 19:127–139

    Article  PubMed  CAS  Google Scholar 

  • West RR, Stafford DA, White AD, Bowen DT, Padua RA (2000) Cytogenetic abnormalities in the myelodysplastic syndromes and occupational or environmental exposure. Blood 95:2093–2097

    PubMed  CAS  Google Scholar 

  • Williamson PJ, Kruger AR, Reynolds PJ, Hamblin TJ, Oscier DG (1994) Establishing the incidence of myelodysplastic syndrome. Br J Haematol 87:743–745

    PubMed  CAS  Google Scholar 

  • Yin SN, Hayes RB, Linet MS, Li GL, Dosemeci M, Travis LB, Zhang ZN, Li DG, Chow WH, Wacholder S, Blot WJ (1996) An expanded cohort study of cancer among benzene-exposed workers in China. Benzene Study Group. Environmental Health Perspectives 104[Suppl 61:1339–1341

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Ninewells Hospital & Medical School, Dundee, DD1 9SY, Scotland, UK

    David T. Bowen M.D.

Authors
  1. David T. Bowen M.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Springer Berlin Heidelberg

About this chapter

Cite this chapter

Bowen, D.T. (2006). Etiology and Epidemiology of MDS. In: Hematologic Malignancies: Myelodysplastic Syndromes. Hematologic Malignancies. Springer, Berlin, Heidelberg. https://doi.org/10.1007/3-540-30794-X_3

Download citation

  • DOI: https://doi.org/10.1007/3-540-30794-X_3

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-26188-9

  • Online ISBN: 978-3-540-30794-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation